176 related articles for article (PubMed ID: 38461339)
1. Dissecting the role of CB
Li X; Hempel BJ; Yang HJ; Han X; Bi GH; Gardner EL; Xi ZX
Eur Neuropsychopharmacol; 2021 Feb; 43():38-51. PubMed ID: 33334652
[TBL] [Abstract][Full Text] [Related]
2. Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB
Chen X; Cowan A; Inan S; Geller EB; Meissler JJ; Rawls SM; Tallarida RJ; Tallarida CS; Watson MN; Adler MW; Eisenstein TK
Br J Pharmacol; 2019 Sep; 176(17):3378-3389. PubMed ID: 31218677
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CB
Gonzalo-Consuegra C; Santos-García I; García-Toscano L; Martín-Baquero R; Rodríguez-Cueto C; Wittwer MB; Dzygiel P; Grether U; de Lago E; Fernández-Ruiz J
Biomed Pharmacother; 2024 May; 174():116473. PubMed ID: 38522237
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific behavioural, metabolic, and immunohistochemical changes after repeated administration of the synthetic cannabinoid AKB48 in mice.
Corli G; Roda E; Tirri M; Bilel S; De Luca F; Strano-Rossi S; Gaudio RM; De-Giorgio F; Fattore L; Locatelli CA; Marti M
Br J Pharmacol; 2024 May; 181(9):1361-1382. PubMed ID: 38148741
[TBL] [Abstract][Full Text] [Related]
5. Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses.
Gobira PH; Joca SR; Moreira FA
Acta Neuropsychiatr; 2024 Apr; 36(2):67-77. PubMed ID: 35993329
[TBL] [Abstract][Full Text] [Related]
6. The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation.
Bow EW; Rimoldi JM
Perspect Medicin Chem; 2016; 8():17-39. PubMed ID: 27398024
[TBL] [Abstract][Full Text] [Related]
7. High-resolution crystal structure of the human CB1 cannabinoid receptor.
Shao Z; Yin J; Chapman K; Grzemska M; Clark L; Wang J; Rosenbaum DM
Nature; 2016 Dec; 540(7634):602-606. PubMed ID: 27851727
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors.
Bo Y; Zhao X; Li L
Clin Sci (Lond); 2024 Mar; 138(6):413-434. PubMed ID: 38505994
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.
Soderstrom K; Soliman E; Van Dross R
Front Pharmacol; 2017; 8():720. PubMed ID: 29066974
[TBL] [Abstract][Full Text] [Related]
10. CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.
Arévalo-Martín A; García-Ovejero D; Gómez O; Rubio-Araiz A; Navarro-Galve B; Guaza C; Molina-Holgado E; Molina-Holgado F
Br J Pharmacol; 2008 Jan; 153(2):216-25. PubMed ID: 17891163
[TBL] [Abstract][Full Text] [Related]
11. CB
Watkins J; Aradi P; Hahn R; Katona I; Mackie K; Makriyannis A; Hohmann AG
bioRxiv; 2024 Mar; ():. PubMed ID: 38558988
[TBL] [Abstract][Full Text] [Related]
12. Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.
Schlienz NJ; Budney AJ; Lee DC; Vandrey R
Curr Addict Rep; 2017 Jun; 4(2):75-81. PubMed ID: 29057200
[TBL] [Abstract][Full Text] [Related]
13. Isolation and Biological Evaluation of Prenylated Flavonoids from
Orazbekov Y; Ibrahim MA; Mombekov S; Srivedavyasasri R; Datkhayev U; Makhatov B; Chaurasiya ND; Tekwani BL; Ross SA
Evid Based Complement Alternat Med; 2018; 2018():1370368. PubMed ID: 29552078
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent hormesis-like effects of the synthetic cannabinoid CP55940 in C57BL/6 mice.
Hodges EL; Marshall JP; Ashpole NM
NPJ Aging Mech Dis; 2020; 6():7. PubMed ID: 32655880
[TBL] [Abstract][Full Text] [Related]
15. One-step, stereoselective synthesis of octahydrochromanes
Slater S; Lasonkar PB; Haider S; Alqahtani MJ; Chittiboyina AG; Khan IA
Tetrahedron Lett; 2018 Feb; 59(9):807-810. PubMed ID: 29880989
[TBL] [Abstract][Full Text] [Related]
16. Cannabis effectiveness on immunologic potency of pulmonary contagion.
Das S; Ghosh A; Karmakar V; Khawas S; Vatsha P; Roy KK; Behera PC
J Basic Clin Physiol Pharmacol; 2024 Apr; ():. PubMed ID: 38635412
[TBL] [Abstract][Full Text] [Related]
17. Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation.
Zeng F; Wade A; Harbert K; Patel S; Holley JS; Dehghanpuor CK; Hopwood T; Marino S; Sophocleous A; Idris AI
Sci Rep; 2024 Mar; 14(1):5782. PubMed ID: 38461339
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.
Quartilho A; Mata HP; Ibrahim MM; Vanderah TW; Porreca F; Makriyannis A; Malan TP
Anesthesiology; 2003 Oct; 99(4):955-60. PubMed ID: 14508331
[TBL] [Abstract][Full Text] [Related]
19. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
